MINDMAZE THERAPEUTICS HOLDING SA
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Market Cap & Net Worth: MINDMAZE THERAPEUTICS HOLDING SA (MMTX)
MINDMAZE THERAPEUTICS HOLDING SA (SW:MMTX) has a market capitalization of $70.83 Million (CHF64.86 Million) as of March 19, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #46235 globally and #137 in its home market, demonstrating a -18.89% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MINDMAZE THERAPEUTICS HOLDING SA's stock price CHF0.43 by its total outstanding shares 152602044 (152.60 Million).
MINDMAZE THERAPEUTICS HOLDING SA Market Cap History: 2025 to 2026
MINDMAZE THERAPEUTICS HOLDING SA's market capitalization history from 2025 to 2026. Data shows growth from $316.65 Million to $70.83 Million (0.00% CAGR).
MINDMAZE THERAPEUTICS HOLDING SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MINDMAZE THERAPEUTICS HOLDING SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MMTX by Market Capitalization
Companies near MINDMAZE THERAPEUTICS HOLDING SA in the global market cap rankings as of March 19, 2026.
Key companies related to MINDMAZE THERAPEUTICS HOLDING SA by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
MINDMAZE THERAPEUTICS HOLDING SA Historical Marketcap From 2025 to 2026
Between 2025 and today, MINDMAZE THERAPEUTICS HOLDING SA's market cap moved from $316.65 Million to $ 70.83 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF70.83 Million | -77.63% |
| 2025 | CHF316.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MINDMAZE THERAPEUTICS HOLDING SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.83 Million USD |
| MoneyControl | $70.83 Million USD |
| MarketWatch | $70.83 Million USD |
| marketcap.company | $70.83 Million USD |
| Reuters | $70.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.